The US subsidiary of Japan’s Sumitomo Pharma announced that the US Food and Drug Administration (FDA) has approved Gemtesa ...

Paxneury and Tuzulby should be granted Europe-wide marketing authorizations for treating attention-deficit hyperactivity, the ...

(RTTNews) - Biohaven Ltd. (BHVN), Monday announced several clinical and regulatory milestones across its proprietary Molecular Degrader of Extracellular Proteins platform as well as its glutamate ...

Alpha-1 adrenergic receptor antagonist (α1-ARA) are well established treatment for benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS). Since BPH and erectile dysfunction ...

Objective: To compare the haemodynamic effects of nebivolol, a highly selective antagonist of 1-adrenergic receptors with additional actions caused via the L-arginine/nitric oxide pathway ...

Landiolol is a selective beta-1 adrenergic receptor blocker with a very short duration of action. The Food and Drug Administration (FDA) has approved Rapiblyk (landiolol) for the short-term ...

β-adrenergic receptors (β-ARs) play a critical role in modulating learning, memory, emotionality, and long-term synaptic plasticity. Recent studies indicate that β-ARs are necessary for long-term ...

In 1991, Strader and colleagues conducted foundational work that paved the way for chemogenetics by altering the β-adrenergic receptor, which belongs to a family known as G-protein-coupled receptors ...

Brian Kobilka of Stanford University became fascinated by adrenergic receptors, a family of GPCRs that respond to adrenalin, when he completed his medical residency. “So many of the drugs we ...

About Rapiblyck TM (landiolol) intravenous [280 mg of landiolol (equivalent to 300 mg of landiolol HCl) in a single-dose vial] Landiolol is an ultra-short-acting adrenergic receptor antagonist, with ...

MEDICATIONS taken by thousands of Brits for to treat an overactive bladder have been linked to dementia in a new study. Some forms of the medication have been found to raise the risk of dementia ...

More research is needed to understand how that impact occurs, but studies on mice suggest that fear and acute stress can stimulate the adrenal glands, triggering adrenergic receptors on immune cells.